Leukocyte 8-oxo-7,8-dihydro-2′-deoxyguanosine and comet assay in epirubicin-treated patients

References

• Keizer HG, Pinedo HM, Schuurhuis GJ, Joenhe H. Doxorubicin (Adriamycin), a critical review of free radical-dependent mechanisms of cytotoxicity. Pharmacol Therapeut 1990;47:219–231.
   PubMed Web of Science ®Google Scholar
• Zunino F, Capranico G. DNA topoisomerase II as the primary target of anti-tumor anthracyclines. Anticancer Drug Des 1990;5(4):307–317, Nov.
   Google Scholar
• Hortobagyi GN. Anthracyclines in the treatment of cancer. An overview. Drugs 1997;54 (Suppl 4):1–7.
   Google Scholar
• Binaschi M, Bigioni M, Cipollone A, Rossi C, Goso C, Maggi CA, Capranico G, Animati F. Anthracyclines: Selected new developments. Curr Med Chem Anti-Cancer Agents 2001;1(2):113–130, Aug.
   Google Scholar
• Sinha BK, Trush MA, Kennedy KA, Mimnaugh EG. Enzymatic activation and binding of adriamycin to nuclear DNA. Cancer Res 1984;44:2892–2896.
   PubMed Web of Science ®Google Scholar
• IVIizutani H, Oikawa S, Hiraku Y, Murata M, Kojima M, Kawanishi S. Distinct mechanisms of site-specific oxidative DNA damage by doxorubicin in the presence of copper(II) and NADPH-cytochrome P450 reductase. Cancer Sci 2003;94(8):686–691, Aug.
   Google Scholar
• Severs NJ, Twist VW, Powell T. Acute effects of Adriamycin on the macromolecular organization of the cardiac muscle cell plasma membrane. Cardioscience 1991;2/1:35–45.
   Google Scholar
• Keefe DL. Anthracycline-induced cardiomyopathy. Semin Oncol 2001;28(4 Suppl 12):2–7, Aug.
   Google Scholar
• Dziegiel P, Surowiak P, Zabel M, Folia. Correlation of histopathological and biochemical appraisal of anthracycline-induced myocardium damage. Histochem Cytobiol 2002;40(2):127–128.
   Google Scholar
• Kelso EJ, Geraghty RF, McDermott BJ, Cameron CH, Nicholls DP, Silke B. Characterisation of a cellular model of cardiomyopathy in the rabbit produced by chronic adminis-tration of the anthracycline, epirubicin. J Mol Cell Cardiol 1997;29(12):3385–3397, Dec.
   Google Scholar
• Nelson MA, Frishman WH, Seiter K, Keefe D, Dutcher J. Cardiovascular considerations with anthracycline use in patients with cancer. Heart Dis 2001;3(3):157–168, May-Jun.
   Google Scholar
• Matesich SM, Shapiro CL. Second cancers after breast cancer treatment. Semin Oncol 2003;30(6):740–748, Dec.
   Google Scholar
• Richard D, Hollender P, Chenais B. Involvement of reactive oxygen species in aclarubicin-induced differentiation and invasiveness of HL-60 leukemia cells. Int J Oncol 2002;21 (2):393–399, Aug.
   Google Scholar
• Schimmel KJ, Richel DJ, vandenBrink RB, Guchelaar HJ. Cardiotoxicity of cytotoxic drugs. Cancer Treat Rev 2004;30(2):181–191, Apr.
   Google Scholar
• Hasinoff BB, Schnabl KL, Marusak RA, Patel D, Huebner E. Dexrazoxane (ICRF-187) protects cardiac myocytes against doxorubicin by preventing damage to mitochondria. Cardio-vasc Toxicol 2003;3(2):89–99.
   Google Scholar
• Pearlman M, Jendiroba D, Pagliaro L, Keyhani A, Liu B, Freireich EJ. Dexrazoxane in combination with anthracyclines lead to a synergistic cytotoxic response in acute myelogenous leukemia cell lines. Leuk Res 2003;27(7):617–626, Jul.
   Google Scholar
• Robert J. Epirubicin. Clinical pharmacology and dose-effect relationship. Drugs 1993;45(Suppl 2):20–30.
   Google Scholar
• Liu FT, Kelsey SM, Newland AC, Jia L. Generation of reactive oxygen species is not involved in idarubicin-induced apoptosis in human leukaemic cells. Br J Haematol 2001; 115(4):817–825, Dec.
   Google Scholar
• Kelso EJ, Geraghty RF, McDermott BJ, Cameron CH, Nicholls DP, Silke B. Characterisation of a cellular model of cardiomyopathy, in the rabbit, produced by chronic adminis-tration of the anthracycline, epirubicin. J Mol Cell Cardiol 1997;29(12):3385–3397, Dec.
   Google Scholar
• DeAtley SM, Aksenov MY, Aksenova MV, Harris B, Hadley R, Harper CP, Carney JM, Butterfield DA. Antioxidants protect against reactive oxygen species associated with adriamycin-treated cardiomyocytes. Cancer Lett 1999;136(1):41–46, Feb 8.
   Google Scholar
• Kumar D, Kirshenbaum L, Li T, Danelisen I, Singal P. Apoptosis in isolated adult cardiomyocytes exposed to adriamycin. Ann N Y Acad Sci 1999;874:156-168, Jun 30.
   Google Scholar
• Loft S, Fisher-Nielsen A, Jeding IB, Vistisen K. 8-Hydroxydeoxyguanosine as a urinary biomarker of oxidative damage. J Toxicol Env Health 1993;40:391–404.
   PubMed Web of Science ®Google Scholar
• Epe B. Genotoxicity of singlet oxygen. Chem Biol Interact 1991;80:239–260.
   PubMed Web of Science ®Google Scholar
• Ravanat JL, DiMascio P, Martinez GR, Medeiros MH. Singlet oxygen induces oxidation of cellular DNA. J Biol Chem 2001;276(8):40601–40604, Feb 23.
   Google Scholar
• Cheng KC, Cahill DS, Kasai H, Nishimura S, Loeb A. 8-Hydroxyguanine, an abundant form of oxidative DNA damage, cause G-T and A-C substitutions. J Biol Chem 1992;264: 166–172.
   Google Scholar
• Jaloszynski P, Masutani C, Hanaoka F, Perez AB, Nishimura S. 8-Hydroxyguanine in a mutational hotspot of the c-Ha-ras gene causes misreplication, 'action-at-a-distance' mutagenesis and inhibition of replication. Nucleic Acids Res 2003;31(21):6085–6095, Nov 1.
   Google Scholar
• Faure H, Mousseau M, Cadet J, Guimier C, Tripier M, Hida H, Favier A. Urine 8-oxo-7,8-deoxyguanosine vs. 5-(Hydroxy-methyl) uracil as DNA oxidation marker in Adriamycin-treated patients. Free Radic Res 1998;28: 377–382.
   Google Scholar
• Hininger I, Chollat-Namy A, Sauvaigo S, Osman M, Faure H, Cadet J, Favier A, Roussel A-M. Assessment of DNA damage by comet assay on frozen total blood: Method and evaluation in smokers and non-smokers. Mutat Res 2004;558:75–80.
   PubMed Web of Science ®Google Scholar
• Steghens J-P, vanKappel AL, Riboli E, Collombel C. Simultaneous measurement of seven carotenoids, retinol and alpha-tocopherol in serum by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1997;694(1):71–81, Jun 20.
   Google Scholar
• Speek AJ, Schrijver J, Schreurs WH. Fluorometric determi-nation of total vitamin C in whole blood by high-performance liquid chromatography with pre-column derivatization. J Chromatogr 1984;305(1):53–60, Jan 13.
   Google Scholar
• ESCODD Comparative analysis of baseline 8-oxo-7,8-dihydroguanine in mammalian cell DNA by different methods in different laboratories: An approach to consensus. Carcino-genesis 2002;23/12:2129–2133.
   Google Scholar
• Singh NP, McCoy MT, Tice RR, Schneider EL. A simple technique for quantitation of low levels of DNA damage in individual cells. Exp Cell Res 1988;175(1):184–191, Mar.
   Google Scholar
• Bender DA. Nutritional biochemistry of the vitamins. Nutritional biochemistry of the vitamins. Cambridge, Mel-bourne, Madrid, Cape Town: Cambridge University Press; 2003., eds.
   Google Scholar
• Kamal-Eldin A, Appelqvist LA. The chemistry and anti-oxidant properties of tocopherols and tocotrienols. Lipids 1996;31:671–701.
   Google Scholar
• Frei B, Forte TM, Ames BN. Ascorbate is an outstanding antioxidant in human blood plasma. Proc Natl Acad Sci 1989;86:6377-6381, USA.
   Google Scholar
• Halpner AD, Handelman GJ, Belmont CA, Blumberg JM. Protection by vitamin C of oxidant-induced loss of vitamin E in rat hepatocytes. J Nutr Biochem 1998;9:355–359.
   Google Scholar
• Di Mascio P, Sundquist AR, Devasagayam TA, Sies H. Assay of lycopene and other carotenoids as singlet oxygen quenchers. Methods Enzymol 1992;213:429–432.
   Google Scholar
• Ravanat JL, Martinez GR, Medeiros MH, DiMascio P, Cadet J. Mechanistic aspects of the oxidation of DNA constituents mediated by singlet molecular oxygen. Arch Biochem Biophys 2004;423(1):23–30, Mar 1.
   Google Scholar
• Faure H, Coudray C, Mousseau M, Ducros V, Douki T, Bianchini F, Cadet J, Favier A. 5-Hydroxymethyluracil excretion, plasma TBARs and plasma antioxidant vitamins in adriamycin-treated patients. Free Radic Biol Med 1996;20(7):979–983.
   PubMed Web of Science ®Google Scholar
• Kaklamani VG, Gradishar WJ. Epirubicin versus doxorubicin: Which is the anthracycline of choice for the treatment of breast cancer? Chin Breast Cancer 2003;(4 Suppl 1):526–533, Apr.
   Google Scholar
• Faure H, Mousseau M, Cadet J, Guimier C, Tripier M, Hida H, Favier A. Urine 8-oxo-7, 8-dihydro-2'-deoxyganosine vs. 5-hydroxymethyluracil as DNA oxidation marker in adriamycin-treated patients. Free Radic Res 1998; 28:377–382.
   Google Scholar
• Doroshow JH, Synold TW, Somlo G, Akman SA, Gajewski E. Oxidative DNA base modifications in peripheral blood mononuclear cells of patients treated with high-dose infusional doxorubicin. Blood 2000;197 (9):2839–2845, May.
   Google Scholar
• Cadet J, Douki T, Ravanat JL. Artifacts associated with the measurement of oxidised DNA bases. Environ Health Perspect 1997;105:1033–1039.
   Google Scholar
• Cadet J, d'Ham C, Douki T, Pouget J, Ravanat JL, Sauvaigo S. Facts and artefacts in the measurement of oxidative base damage to DNA. Free Radic Res 1998;29:541–550.
   PubMed Web of Science ®Google Scholar
• Ravanat JL, Turesky RJ, Gremaud E, Trudel U, Stadler RH. Determination of 8-oxoguanine in DNA by gas chromato-graphy-mass spectrometry and HPLC- electrochemical detection: Overestimation of the background level of the oxidised base by the gas chromatography-mass spectrometry assay. Chem Res Toxicol 1995;8(8):1039–1045, Dec.
   Google Scholar
• Ravanat JL, Douki T, Turesky RJ, Cadet J. Measurement of oxidised bases in DNA. Comparison between HPLC-EC and GC-MS assays. J Chim Phys 1997;94:306–312.
   Google Scholar